Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 1, 2010, Pages 15-21

  Chonchol, M ^a   Katz, R ^b   Fried, L F ^c,f   Sarnak, M J ^d   Siscovick, D S ^e   Newman, A B ^f   Strotmeyer, E S ^f   Bertoni, A ^g   Shlipak, M G ^h  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; Elderly; Glycosylated hemoglobin; Hemoglobin A1c; Mortality

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; MALE; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICS; STROKE; UNITED STATES;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; STATISTICS AS TOPIC; STROKE; UNITED STATES;

EID: 72649096738     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.02.007     Document Type: Article

References (25)

1. Coutinho M., Gerstein H.C., Wang Y., and Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22 (1999) 233-240
2. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141 (2004) 413-420
3. Misciagna G., De Michele G., and Trevisan M. Non enzymatic glycated proteins in the blood and cardiovascular disease. Curr Pharm Des 13 (2007) 3688-3695
4. Zieman S.J., and Kass D.A. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease. Drugs 64 (2004) 459-470
5. Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., and Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295 (1976) 417-420
6. 1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18 (1995) 440-447
7. 1c measurements - a consensus statement. Diabet Med 17 (2000) 5-6
8. Gerstein H.C., Pogue J., Mann J.F., Lonn E., Dagenais G.R., McQueen M., et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 248 (2005) 1749-1755
9. Levitan E.B., Liu S., Stampfer M.J., Cook N.R., Rexrode K.M., Ridker P.M., et al. HbA(1c) measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia 51 (2008) 267-275
10. Pradhan A.D., Rifai N., Buring J.E., and Ridker P.M. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 120 (2007) 720-727
11. Selvin E., Coresh J., Golden S.H., Brancati F.L., Folsom A.R., and Steffes M.W. Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. Arch Intern Med 165 (2005) 1910-1916
12. Blake G.J., Pradhan A.D., Manson J.E., Williams G.R., Buring J., Ridker P.M., et al. Hemoglobin A1c level and future cardiovascular events among women. Arch Intern Med 164 (2004) 757-761
13. Selvin E., Coresh J., Shahar E., Zhang L., Steffes M., and Sharrett A.R. Glycaemia (haemoglobin A1c) and incident ischaemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Lancet Neurol 4 (2005) 821-826
14. Park S., Barrett-Connor E., Wingard D.L., Shan J., and Edelstein S. GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care 19 (1996) 450-456
15. Fried L.P., Borhani N.O., Enright P., Furberg C.D., Gardin J.M., Kronmal R.A., et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1 (1991) 263-276
16. Cushman M., Cornell E.S., Howard P.R., Bovill E.G., and Tracy R.P. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41 (1995) 264-270
17. Ives D.G., Fitzpatrick A.L., Bild D.E., Psaty B.M., Kuller L.H., Crowley P.M., et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5 (1995) 278-285
18. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
19. Psaty B.M., Lee M., Savage P.J., Rutan G.H., German P.S., and Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 45 (1992) 683-692
20. Shlipak M.G., Fried L.F., Cushman M., Manolio T.A., Peterson D., Stehman-Breen C., et al. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293 (2005) 1737-1745
21. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al., National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
22. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
23. Macy E.M., Hayes T.E., and Tracy R.P. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 43 (1997) 52-58
24. de Vegt F., Dekker J.M., Ruhé H.G., Stehouwer C.D., Nijpels G., Bouter L.M., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
25. Meigs J.B., Nathan D.M., D'Agostino Sr. R.B., and Wilson P.W. Framingham Offspring Study. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25 (2002) 1845-1850